The Vanguard Group 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:59 pm Unchanged | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 3,156,005 9.040% | 0 (Unchanged) | Filing |
| 2024-11-04 1:30 pm Purchase | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 3,156,005 9.040% | 1,099,784 (+53.49%) | Filing |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 2,056,221 5.980% | 2,056,221 (New Position) | Filing |